Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study.

Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM. · 2012

Read Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. by Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3580400.txt.

Description

John Ringman and colleagues ran a clinical trial of curcumin for Alzheimer disease in Alzheimer's Research and Therapy in 2012. Curcumin, the yellow compound in turmeric, fights oxidation and inflammation in the lab and reduces amyloid clumping in mouse models. Those results made it a candidate treatment, but human evidence was missing. The trial tested safety and early signs of benefit in people with mild to moderate disease.

Thirty-six patients took placebo or curcumin at two or four grams a day for twenty-four weeks, with an open extension after. The compound was mostly well tolerated, though three people on it quit with gut symptoms. No differences appeared in thinking scores, daily function, or blood and spinal fluid markers. Blood levels of curcumin stayed very low, which the authors flag as the likely weak point: the body barely absorbs this formulation.

Catalog record

CREATORRingman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3580400

Browse the full library · About the Tower of Babel